The company Bio-Peptide presented new data on peptide drugs

April 14 in the XVIII Russian National Congress "Man and Medicine" Director of the St. Petersburg Institute of Bioregulation and Gerontology of the North-West Branch of the Russian Academy of Medical Sciences, corresponding member of the Academy of Medical Sciences Vladimir Havinson presented a study on the clinical use of peptide bio-regulators.

In particular, according to the scientist, the therapeutic results of the use of peptides by the liquidators of the Chernobyl nuclear power plant and affected by the disaster submarine "Komsomolets" show that the peptide Bioregulators radioprotectors are effective and can be used for the prevention and treatment of radiation injuries.
The data presented by Professor Havinson, are the result of more than 40 years of work by the team of scientists from the Military Medical Academy. SM Kirov in St. Petersburg, and themselves peptide Bioregulators represent innovation of our scientists.

In Soviet times, the study carried out "behind closed doors", but now, according to Professor Havinson, "scientific advances have given the practical result: peptide therapy is already widely applied in everyday life." In addition, he said, "the latest clinical data on the properties of peptide drugs antiraditsionnyh particularly relevant for residents of the Far East countries, in the light of recent events in Japan."

Currently, scientists are cooperating with "Bio Peptide", the Russian manufacturer of innovative medicines. Speaking about the prospects of this cooperation, the CEO of "Bio-Peptide" Victor Sachs, said: "It's no secret that the Russian pharmaceutical industry does not have enough of their own development and production of export-oriented. Backed by strong science base, we produce truly innovative products. Our designs are patented in 13 countries, including the United States, and we are not going to stop. "

The company plans to record two drugs as medicines, and later assumed the registration process and a number of other drugs. In addition, "Peptide Bio" pays special attention to the development of scientific potential, currently in the review process is the application of the research division of the company to participate in the Skolkovo project.

About "The peptide Bio»

Corporation "Bio-Peptide" — Russian biotechnology company founded in 2008. The company is engaged in the development, manufacture and sale of a fundamentally new pharmaceutical products — peptide bio-regulators, maintains and repairs the human body at the cellular level.

"Peptide Bio" is growing rapidly and currently implements successful joint projects with major players in the pharmaceutical market — pharmacy chains "36.6", "Riegle," "Doctor century", "Old Doctor" distributors "SIA International", "Protek" "Quatrain", etc.

In addition, the company actively uses its own development for the benefit of the domestic professional sports, working with the Olympic team of Russia in rhythmic gymnastics, led by Irina Viner and honored coach of Russia figure skating Tatiana Tarasova.

On the developers of peptide bio-regulators

In the 70-ies of XX century in the Military Medical Academy. SM Kirov in St. Petersburg under the leadership of V.H.Havinsona began work on the release of short peptides from various tissues of animals, the study of their impact on human organs and tissues when entering them into the body. To date, a team led by Chief gerontologist St. Petersburg, corresponding member of the Academy of Medical Sciences Professor WH Havinson developed and registered more than 40 peptide bio-regulators. Currently two products based on short peptides tested registration process as medicaments.

Like this post? Please share to your friends: